Novel Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Necrotizing Pneumonia Complicated by Empyema: A Case Report

Dana J. Holger; Ashlan J. Kunz Coyne; Jing J. Zhao; Avnish Sandhu; Hossein Salimnia; Michael J. Rybak

doi:10.1093/ofid/ofac092

Novel Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Necrotizing Pneumonia Complicated by Empyema: A Case Report

Dana J. Holger, Ashlan J. Kunz Coyne, Jing J. Zhao, Avnish Sandhu, Hossein Salimnia, Michael J. Rybak

Pharmacy Practice and Science

Research output: Contribution to journal › Article › peer-review

24 Scopus citations

Abstract

We report our clinical and laboratory experience treating a 50-year-old patient who was critically ill with extensively drug-resistant Acinetobacter baumannii necrotizing pneumonia complicated by empyema in Detroit, Michigan. A precision medicine approach using whole-genome sequencing, susceptibility testing, and synergy analysis guided the selection of rational combination antimicrobial therapy.

Original language	English
Article number	ofac092
Journal	Open Forum Infectious Diseases
Volume	9
Issue number	4
DOIs	https://doi.org/10.1093/ofid/ofac092
State	Published - Apr 1 2022

Bibliographical note

Publisher Copyright:
© 2022 The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Keywords

Acinetobacter baumannii
antimicrobial resistance
combination therapy
pneumonia
sulbactam-durlobactam

ASJC Scopus subject areas

Oncology
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/ofid/ofac092

Cite this

@article{cc3780a59d794de0953bb9d4c0f3ed4f,

title = "Novel Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Necrotizing Pneumonia Complicated by Empyema: A Case Report",

abstract = "We report our clinical and laboratory experience treating a 50-year-old patient who was critically ill with extensively drug-resistant Acinetobacter baumannii necrotizing pneumonia complicated by empyema in Detroit, Michigan. A precision medicine approach using whole-genome sequencing, susceptibility testing, and synergy analysis guided the selection of rational combination antimicrobial therapy.",

keywords = "Acinetobacter baumannii, antimicrobial resistance, combination therapy, pneumonia, sulbactam-durlobactam",

author = "Holger, \{Dana J.\} and \{Kunz Coyne\}, \{Ashlan J.\} and Zhao, \{Jing J.\} and Avnish Sandhu and Hossein Salimnia and Rybak, \{Michael J.\}",

note = "Publisher Copyright: {\textcopyright} 2022 The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.",

year = "2022",

month = apr,

day = "1",

doi = "10.1093/ofid/ofac092",

language = "English",

volume = "9",

number = "4",

}

TY - JOUR

T1 - Novel Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Necrotizing Pneumonia Complicated by Empyema

T2 - A Case Report

AU - Holger, Dana J.

AU - Kunz Coyne, Ashlan J.

AU - Zhao, Jing J.

AU - Sandhu, Avnish

AU - Salimnia, Hossein

AU - Rybak, Michael J.

PY - 2022/4/1

Y1 - 2022/4/1

N2 - We report our clinical and laboratory experience treating a 50-year-old patient who was critically ill with extensively drug-resistant Acinetobacter baumannii necrotizing pneumonia complicated by empyema in Detroit, Michigan. A precision medicine approach using whole-genome sequencing, susceptibility testing, and synergy analysis guided the selection of rational combination antimicrobial therapy.

AB - We report our clinical and laboratory experience treating a 50-year-old patient who was critically ill with extensively drug-resistant Acinetobacter baumannii necrotizing pneumonia complicated by empyema in Detroit, Michigan. A precision medicine approach using whole-genome sequencing, susceptibility testing, and synergy analysis guided the selection of rational combination antimicrobial therapy.

KW - Acinetobacter baumannii

KW - antimicrobial resistance

KW - combination therapy

KW - pneumonia

KW - sulbactam-durlobactam

UR - https://www.scopus.com/pages/publications/85128532343

UR - https://www.scopus.com/inward/citedby.url?scp=85128532343&partnerID=8YFLogxK

U2 - 10.1093/ofid/ofac092

DO - 10.1093/ofid/ofac092

M3 - Article

AN - SCOPUS:85128532343

SN - 2328-8957

VL - 9

JO - Open Forum Infectious Diseases

JF - Open Forum Infectious Diseases

IS - 4

M1 - ofac092

ER -

Novel Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Necrotizing Pneumonia Complicated by Empyema: A Case Report

Abstract

Bibliographical note

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this